Related Experiment Videos
Over-additive protective effect of dizocilpine and NBQX against neuronal damage
K Lippert1, M Welsch, J Krieglstein
1Institut für Pharmacokologie und Toxikologie, Fachbereich Pharmazie und Lebensmittelchemie, Philipps-Universität, Marburg, Germany.
European Journal of Pharmacology
|March 3, 1994
Summary
Combining dizocilpine and NBQX, N-methyl-D-aspartate and AMPA receptor antagonists, offers enhanced neuroprotection against neuronal damage. This combination demonstrated significant therapeutic potential in both in vitro and in vivo models of brain injury.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Glutamate receptor antagonists like dizocilpine (NMDA receptor) and NBQX (AMPA receptor) show neuroprotective properties.
- Neuronal damage from hypoxia, ischemia, and excitotoxicity is a significant clinical concern.
Purpose of the Study:
- To investigate the combined neuroprotective effects of dizocilpine and NBQX.
- To determine if combining these antagonists yields enhanced neuronal protection compared to individual treatments.
Main Methods:
- Primary cultures of rat hippocampal neurons were subjected to glutamate intoxication.
- In vivo studies involved mice with focal cerebral ischemia and rats with global forebrain ischemia.
- Dose-dependent effects of dizocilpine and NBQX were assessed.
Main Results:
- Both dizocilpine and NBQX individually increased neuronal viability in a dose-dependent manner.
- Combined administration of dizocilpine and NBQX exhibited an over-additive neuroprotective effect.
- The drug combination proved effective in vivo models of both focal and global cerebral ischemia.
Conclusions:
- Co-administration of NMDA and AMPA receptor antagonists provides superior neuroprotection.
- This combined therapeutic strategy holds significant promise for treating ischemic brain injury.
- Further clinical investigation into this combined neuroprotective approach is warranted.